Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine ear drops added to usual care for children with acute otitis media
NL-OMON54000Phase 3Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine in acute otitis media (AOM) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Mean parent-reported ear pain score over the first 3 days. Started Oct 2021; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NL-OMON54000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54000.